11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in CML17332A680 |
Person / Time |
---|
Site: |
Northwest Medical Isotopes |
---|
Issue date: |
11/24/2017 |
---|
From: |
Denise Mcgovern, Annette Vietti-Cook NRC/SECY |
---|
To: |
Buntin D, Greitens E, Hawley J State of MO, Attorney General, State of MO, Dept of Natural Resources, State of MO, Governor |
---|
McGovern, Denise, SECY |
Shared Package |
---|
ML1331B431 |
List: |
---|
References |
---|
NRC-2013-0235 |
Download: ML17332A680 (10) |
|
|
---|
Category:Federal Register Notice
MONTHYEARML22147A1622022-07-13013 July 2022 FRN - Northwest Medical Isotopes, LLC - Termination of Construction Permit CPMIF-002 ML18163A0692018-11-0101 November 2018 Federal Register Notice Exemption for Northwest Medical Isotopes, LLC; Medical Radioisotope Production Facility NRC-2018-0225, Federal Register Notice Exemption for Northwest Medical Isotopes, LLC; Medical Radioisotope Production Facility2018-11-0101 November 2018 Federal Register Notice Exemption for Northwest Medical Isotopes, LLC; Medical Radioisotope Production Facility ML18038B1332018-05-0909 May 2018 Federal Register Notice - Northwest Medical Isotopes, LLC Construction Permit NRC-2013-0235, Federal Register Notice - Northwest Medical Isotopes, LLC Construction Permit2018-05-0909 May 2018 Federal Register Notice - Northwest Medical Isotopes, LLC Construction Permit ML17339A1972017-11-27027 November 2017 11-27-17 Ltr to Maurice Graham, Et Al., from Annette Vietti-Cook Notifying Him of That the Commission Is Convening an Evidentiary Hearing on the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facilit ML17332A6802017-11-24024 November 2017 11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in C ML17331B4452017-11-22022 November 2017 11-22-17 Letter to Bill Anoatubby Et Al, Governor, Chickasaw Nation from Annette Vietti-Cook Notifying Him of the Evidentiary Hearing for the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facility i ML17331B4102017-11-21021 November 2017 Federal Register Notice on Construction Permit Application; Notice of Hearing - Northwest Medical Isotopes, LLC (Docket No. 50-609; NRC-2013-0235) ML16291A5132016-11-0303 November 2016 Nwmi Deis FRN - Notice of Availability and Public Meeting ML16033A1792016-05-18018 May 2016 FRN Northwest Medical Isotopes LLC - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Regarding Application for Construction Permit (TAC No. MF6138) ML15300A4682015-11-12012 November 2015 FRN Notice.:Northwest Medical Isotopes, LLC- Notice of Intent to Prepare an Environmental Impact Statement and Conduct Scoping Process for Proposed Radioisotope Production Facility 2022-07-13
[Table view] Category:Letter
MONTHYEARML22147A1572022-07-11011 July 2022 Northwest Medical Isotopes, LLC - Termination of Construction Permit CPMIF-002 ML22084A0042022-02-0707 February 2022 Northwest Medical Isotopes, LLC (Nwmi), Request for Termination of Construction Permit No. CPMIF-002 ML19315A0132019-11-11011 November 2019 Northwest Medical Isotopes, LLC (Nwmi) Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 (Docket No. 50-609), November 11, 2019 ML18163A0612018-11-16016 November 2018 Letter: Approval of Request for Exemption from Requirements of Title 10 of the Code of Federal Regulations, Paragraph 70.21 (F) ML18318A3052018-11-0909 November 2018 Northwest Medical Isotopes, LLC (Nwmi) - Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 ML18113A5042018-05-17017 May 2018 Letter to L. Tippet-Mosby Missouri Department of Natural Resources Request for Comments on North West Medical Isotopes Draft Environmental Assessment ML18037A3082018-05-0909 May 2018 Northwest Medical Isotopes, LLC - Transmittal Letter Regarding Issuance of Construction Permit for a Medical Radioisotope Production Facility ML18110A6072018-04-26026 April 2018 Acceptance for Review of Request for Exemption from Requirements of 10 CFR 70.21(F) for the Target Fabrication Portion of the Northwest Medical Isotopes Radioisotope Production Facility ML18088A1752018-03-12012 March 2018 Supplemental Information Request - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(F), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility ML17355A5292017-12-21021 December 2017 RIC Invitation Letter External Speaker 2018 Haass ML17362A0402017-12-18018 December 2017 Northwest Medical Isotopes, LLC - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70 21(F), Filing. ML17353A0982017-12-18018 December 2017 Letter from Missouri Department of Natural Resources Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17349A1732017-12-14014 December 2017 Letter to Chairman Kristine Svinicki from Senators Ron Wyden and Claire Mccaskill Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17324A4122017-12-0808 December 2017 LTR-17-0431-1 - Report on Safety Aspects of the Construction Permit Application for Nwmi Medical Radioisotope Production Facility ML17339A1972017-11-27027 November 2017 11-27-17 Ltr to Maurice Graham, Et Al., from Annette Vietti-Cook Notifying Him of That the Commission Is Convening an Evidentiary Hearing on the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facilit ML17332A6802017-11-24024 November 2017 11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in C ML17331B4452017-11-22022 November 2017 11-22-17 Letter to Bill Anoatubby Et Al, Governor, Chickasaw Nation from Annette Vietti-Cook Notifying Him of the Evidentiary Hearing for the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facility i ML17310A3662017-11-16016 November 2017 Transmittal Letter of Safety Evaluation Report for the Northwest Medical Isotopes, LLC, Constuction Permit Application ML17310B5112017-11-0606 November 2017 Report on the Safety Aspects of the Construction Permit for Northwest Medical Isotopes, LLC, Radioisotope Production Facility ML17283A1092017-09-28028 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 ML17283A1082017-09-28028 September 2017 Responses to Advisory Committee on Reactor Safeguards Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMl-2013-021, Construction Permit Application for Radioisotope Production, at Meeting on September 21, 2017 ML17262A1112017-09-21021 September 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit ML17265A0482017-09-18018 September 2017 Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; & ML17268A3032017-09-15015 September 2017 Ltr from Missouri Dept of Natural Resources Dtd Sep 15, 2017, to Nwmi, Issuing 401 Water Quality Certification ML17221A1992017-08-0707 August 2017 Transmittal of Revision 1 of Chapters 10.0, 11.0, 12.0 (Including Appendices 12A, 12b and 12C) and 14.0 and Revision 2 of Chapters 2.0, 3.0, 6.0, 7.0, 8.0 and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Productio ML17193A4252017-07-0606 July 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 3.0, 6.0, 7.0, 8.0, 9.0, and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Production ML17158B2672017-06-0303 June 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 1.0, 2.0, 4.0, and 5.0 of NWMl-2013-021, Construction Permit Application for Radioisotope Production Facility ML17157B4112017-06-0202 June 2017 Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections ML17111A7252017-05-30030 May 2017 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, LLC Construction Permit Application ML17086A5822017-05-30030 May 2017 Letter from NRC to Nwmi Carolyn Haass Transmitting Nwmi Final EIS ML17132A3912017-05-24024 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility Construction Permit ML17096A1832017-05-23023 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application (CAC No. MF6135) to N. Fowler ML17114A2532017-05-22022 May 2017 Final EIS for Nwmi Construction Permit and Response to Comments on the Draft EIS from EPA ML17121A3562017-05-22022 May 2017 Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement ML17128A0652017-04-28028 April 2017 Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) ML17069A4082017-03-29029 March 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17061A1592017-03-22022 March 2017 Proprietary Determination Regarding Northwest Medical Isotopes Presentation November 10, 2016 ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17048A2712017-02-27027 February 2017 Northwest Medical Isotopes, LLC - Proprietary Determination Regarding Request for Information Responses Dated November 28, 2016 ML16344A0522016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information ML16305A2442016-11-10010 November 2016 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, Llc Construction Permit Application ML16294A1352016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16293A8812016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16308A4342016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, Llc Radioisotope Production Facility Construction Permit Application (Cac No. MF6135) ML16295A1292016-11-0404 November 2016 Notice of Availability of Nwmi DEIS-Tribal ML16272A2942016-11-0101 November 2016 NRC to FWS Availability of the NWMI Draft EIS and Concurrence with ESA Determinations ML16294A4792016-11-0101 November 2016 Letter to Nicholas Fowler, Nwmi, Transmitting the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application ML16292A7242016-11-0101 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application 2022-07-11
[Table view] |
Text
[7590-01-P]
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-609; NRC-2013-0235]
Northwest Medical Isotopes, LLC; Notice of Hearing AGENCY: Nuclear Regulatory Commission.
ACTION: Construction permit appl ication ; Notice of hearing .
SUMMARY
- The U.S . Nuclear Regulatory Commission (NRC or the Commission) will convene an evidentiary session to receive testimony and exhibits in the uncontested proceeding regarding the application from Northwest Medical Isotopes, LLC (NWMI) , for a construction perm it (CP) to construct a medical radioisotope production facility in Columbia , Missouri. This mandatory hearing will consider safety and environmental matters relating to the requested CP.
DATES: The hearing will be held on January 23, 2018, beginning at 9:00 a.m. Eastern Time.
For the schedule for submitting pre-filed documents and deadlines affecting Interested Government Participants, see Section VI of the SUPPLEMENTARY INFORMATION section of this document.
ADDRESSES: Please refer to Docket ID 50-609 when contacting the NRC about the availability of information regard ing this document. You may obtain publicly available information related to this document using any of the following methods:
- NRC's Electronic Hearing Docket: You may obtain publicly available documents related to this hearing on line at http:llwww.nrc.gov/about-nrclregulatoryladiudicatory.html.
- NRC's Agencywide Documents Access and Management System (ADAMS):
You may obtain publicly available documents online in the ADAMS Public Documents collection at http:llwww.nrc.gov/reading-rmladams.html. To begin the search , select "ADAMS Public Documents," and then select "Begin Web-based ADAMS Search." For problems with ADAMS ,
please contact the NRC's Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or by e-mail to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced (if that document is available in ADAMS) is provided the first time that a document is referenced .
- NRC's PDR: You may examine and purchase copies of public documents at the NRC's PDR , Room 01-F21, One White Flint North , 11555 Rockville Pike, Rockville , Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Denise McGovern , Office of the Secretary, U.S.
Nuclear Regulatory Commission , Washington, DC 20555-0001 , telephone : 301-415-0681 ;
e-mail : Denise. McGovern@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. BACKGROUND The Commission hereby gives notice that , pursuant to Section 189a of the Atomic Energy Act (AEA) of 1954, as amended (the Act) , it will convene an evidentiary session to receive testimony and exhibits in the proceeding regarding the NWMI application for a CP under part 50 of title 1O of the Code of Federal Regulations (10 CFR) , to construct a medical radioisotope production facility in Columbia, Missouri.
Part one of NWMl's two-part application was submitted by letter dated February 5, 2015 (ADAMS Accession No. ML15086A261), and by letter dated July 20, 2015 (ADAMS Accession No. ML 1521 OA 182), NWMI submitted the second part of its application. Revision 3 of the application may be viewed at ADAMS Accession No. ML17257A019 .
The NRC staff's Environmental Impact Statement and Safety Evaluation Report may be viewed at ADAMS Accession Nos. ML17130A862 and ML17310A365, respectively. This mandatory hearing will concern safety and environmental matters relating to the requested construction permit application, as more fully described below.
II. EVIDENTIARY UNCONTESTED HEARING The Commission will conduct this hearing beginning at 9:00 a.m., Eastern Time on January 23, 2018, at the Commission's headquarters in Rockville, Maryland . The hearing will continue on subsequent days, if necessary.
Ill. PRESIDING OFFICER The Commission is the presiding officer for this proceeding.
IV. MATTERS TO BE CONSIDERED The matter at issue in this proceeding is whether the review of the NWMI CP application by the Commission's staff has been adequate to support the findings found in 10 CFR 50.35, 50.40, 50.50, and 10 CFR 51 .105. Those findings are as follows :
Issues Pursuant to the Atomic Energy Act of 1954, as Amended With respect to the CP: {1) whether the applicant has described the proposed design of the facility, including , but not limited to , the principal architectural and engineering criteria for the design , and has identified the major features or components incorporated therein for the protection of the health and safety of the public; (2) whether such further technical or design information as may be required to complete the safety analysis, and which can reasonably be left for later consideration , will be supplied in the final safety analysis report (3) whether safety features or components , if any, which require research and development have been described by the applicant and the applicant has identified, and there will be conducted , a research and development program reasonably designed to resolve any safety questions associated with such features or components; (4) whether on the basis of the foregoing , there is reasonable assurance that, (i) such safety questions will be satisfactorily resolved at or before the latest date stated in the application for completion of construction of the proposed facility, and (ii) taking into consideration the site criteria contained in 10 CFR part 100, the proposed facility can be constructed and operated at the proposed location without undue risk to the health and safety of the public; (5) whether there is reasonable assurance (i) that the construction of the facility will not endanger the health and safety of the public, and (ii) that construction activities can be conducted in compliance with the Commission 's regulations ; (6) whether the applicant is technically and financially qualified to engage in the proposed activities in accordance with the Commission 's regulations in chapter I of title 10 of the CFR; (7) whether the issuance of a permit for the construction of the facility to the applicant will not, in the opinion of the Commission , be inimical to the common defense and security or to the health and safety of the public; and (8) whether the application meets the standards and requirements of the AEA and the Commission 's regulations, and that notifications, if any, to other agencies or bodies have been duly made.
Issues Pursuant to the National Environmental Policy Act (NEPA) of 1969 With respect to the CP: (1) determine whether the requirements of Sections 102(2)(A),
(C) , and (E) of NEPA and the applicable regulations in 10 CFR part 51 have been met; (2) independently consider the final balance among conflicting factors contained in the record of the proceeding with a view to determining the appropriate action to be taken ; (3) determine, after weighing the environmental , economic, technical , and other benefits against environmental and other costs, and considering reasonable alternatives, whether the construction permit should be issued , denied, or appropriately conditioned to protect environmental values; and (4) determine whether the NEPA review conducted by the NRC staff has been adequate.
V. SCHEDULE FOR SUBMITTAL OF PRE-FILED DOCUMENTS No later than January 2, 2018, unless the Commission directs otherwise, the NRC staff and the applicant shall submit a list of its anticipated witnesses for the hearing.
No later than January 2, 2018, unless the Commission directs otherwise, the applicant shall submit its pre-filed written testimony. The NRC staff submitted its pre-filed testimony on November 16, 2017.
The Commission may issue written questions to the applicant or the NRC staff before the hearing . If such questions are issued, an order containing such questions will be issued no later than December 20, 2017 . Responses to such questions are due January 2, 2018, unless the Commission directs otherwise.
VI. INTERESTED GOVERNMENT PARTICIPANTS No later than December 18, 2017, any interested State, local government body, or Federally-recognized Indian Tribe may file with the Commission a statement of any issues or questions that the State, local government body, or Indian Tribe wishes the Commission to give particular attention as part of the uncontested hearing process. Such statement may be accompanied by any supporting documentation that the State, local government body, or Indian Tribe sees fit to provide. Any statements and supporting documentation (if any) received by the Commission using the agency's E-filing system 1 by the deadline indicated above will be made part of the record of the proceeding. The Commission will use such statements and documents as appropriate to inform its pre-hearing questions to the NRC staff and applicant, its inquiries at the oral hearing , and its decision following the hearing . The Comm ission may also request, no later than December 20, 2017, that one or more particular States, local government bodies, or Indian Tribes send one representative each to the evidentiary hearing to answer Commission questions and/or make a statement for the purpose of assisting the Commission 's exploration of one or more of the issues raised by the State, local government body, or Indian Tribe , in the pre-hearing filings described above. The decision whether to request the presence of a representative of a State, local government body, or Indian Tribe at the evidentiary hearing to make a statement and/or answer Commission questions is solely at the Commission's discretion . The Commission's request will specify the issue or issues that each representative should be prepared to address.
Many of the procedures and rights applicable to the inherently adversarial nature of NRC's contested hearing process are not available in this uncontested hearing. Participation in the NRC's contested hearing process is governed by 10 CFR 2.309 (for persons or entities, including a State, local government, or Indian Tribe seeking to file contentions of their own) and 10 CFR 2.31 S(c) (for an interested State, local government, or Federally-recognized Indian Tribe seeking to participate with respect to cor:itentions filed by others). Participation in this 1 The process for accessing and using the agency's E-filing system is described in the May 24, 2016, notice of hearing (81 FR 32793) that was issued by the Commission for this proceeding. Participants who are unable to use the electronic information exchange (EIE) , or who will have difficulty complying with EIE requirements in the time frame provided for submission of written statements, may provide their statements by electronic mail to hearingdocket@nrc.gov.
uncontested hearing does not affect the right of a State, a local government, or an Indian Tribe to participate in the separate contested hearing process.
Dated at Rockville , Maryland, this 21st day of November, 2017.
For the Nuclear Regulatory Commission .
Annette L. Vietti-Cook, Secretary of the Commission .